ES2176201T3 - Derivados de 4-difenilmetil piperidina y procedimiento de preparacion. - Google Patents

Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.

Info

Publication number
ES2176201T3
ES2176201T3 ES93907333T ES93907333T ES2176201T3 ES 2176201 T3 ES2176201 T3 ES 2176201T3 ES 93907333 T ES93907333 T ES 93907333T ES 93907333 T ES93907333 T ES 93907333T ES 2176201 T3 ES2176201 T3 ES 2176201T3
Authority
ES
Spain
Prior art keywords
piperidine
derivatives
difenylmetil
preparation procedure
ch2oh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907333T
Other languages
English (en)
Inventor
Chi-Hsin Richard King
Michele A Kaminski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2176201T3 publication Critical patent/ES2176201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Abstract

LA PRESENTE INVENCION ES RELATIVA A UN NUEVO PROCESO PARA PREPARAR CIERTOS DERIVADOS DE PIPERIDINA DE FORMULA (I) Y (II) EN DONDE R1 REPRESENTA HIDROGENO O HIDROXI, R2 REPRESENTA HIDROGENO; O R1 Y R2 TOMADOS JUNTOS FORMAN UN SEGUNDO ENLACE ENTRE LOS ATOMOS DE CARBONO QUE SOPORTAN R1 Y R2; N ES UN ENTERO DE DESDE 1 A 5; R3 ES -CH2OH, -CH2OH, -COOH O -COOALQUILO EN DONDE EL ALQUILO CENTRAL TIENE DE 1 A 6 ATOMOS DE CARBONO Y ES LINEAL O RAMIFICADO; CADA A ES HIDROGENO O HIDROXI. Y SALES FARMACEUTICAMENTE ACEPTABLES E ISOMEROS OPTICOS INDIVIDUALES DE ELLOS.
ES93907333T 1992-04-10 1993-03-10 Derivados de 4-difenilmetil piperidina y procedimiento de preparacion. Expired - Lifetime ES2176201T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86726192A 1992-04-10 1992-04-10
US1725193A 1993-02-25 1993-02-25

Publications (1)

Publication Number Publication Date
ES2176201T3 true ES2176201T3 (es) 2002-12-01

Family

ID=26689638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907333T Expired - Lifetime ES2176201T3 (es) 1992-04-10 1993-03-10 Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.

Country Status (19)

Country Link
EP (1) EP0635004B1 (es)
JP (3) JP3686950B2 (es)
KR (1) KR100257805B1 (es)
AR (1) AR253777A1 (es)
AT (1) ATE220666T1 (es)
AU (1) AU671822B2 (es)
CA (1) CA2117892C (es)
DE (1) DE69332117T2 (es)
DK (1) DK0635004T3 (es)
ES (1) ES2176201T3 (es)
FI (2) FI106454B (es)
HU (1) HU226561B1 (es)
IL (1) IL105328A (es)
MX (1) MX9302076A (es)
NO (5) NO305076B1 (es)
NZ (1) NZ251132A (es)
PT (1) PT635004E (es)
TW (1) TW362096B (es)
WO (1) WO1993021156A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226242B1 (en) * 1992-08-03 2008-07-28 Sepracor Inc Use of terfenadin carboxylic acid, their salt and optically pure isomers for the preparation of pharmaceutical compositions, and pharmaceutical compositions against allergic disorders
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DE69433346T2 (de) * 1993-06-24 2004-09-09 Albany Molecular Research, Inc. Herstellung von Verbindungen, die in der Produktion von Piperidin-Derivaten nützlich sind
AU699559B2 (en) 1993-06-25 1998-12-10 Aventisub Ii Inc. Novel intermediates for the preparation of antihistaminic piperidine derivatives
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
CA2189007C (en) * 1994-05-18 2004-03-02 Daniel R. Henton Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
ATE226819T1 (de) 1995-02-28 2002-11-15 Aventis Pharma Inc Arzneizubereitungen für piperidinalkanolderivate
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
BR9911794A (pt) * 1998-07-02 2001-03-27 Aventis Pharma Inc Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
PL366576A1 (en) * 2001-04-09 2005-02-07 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine hydrochloride
ITRM20010260A1 (it) 2001-05-17 2002-11-18 Dinamite Dipharma S P A In For Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz
US6743941B2 (en) 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
EP1474392A1 (en) 2002-06-10 2004-11-10 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20070987A1 (it) 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives

Also Published As

Publication number Publication date
TW362096B (en) 1999-06-21
JP2005213268A (ja) 2005-08-11
DE69332117D1 (de) 2002-08-22
JP3686950B2 (ja) 2005-08-24
HUT70517A (en) 1995-10-30
ATE220666T1 (de) 2002-08-15
HU226561B1 (en) 2009-04-28
NO305025B1 (no) 1999-03-22
JP4266184B2 (ja) 2009-05-20
DK0635004T3 (da) 2002-11-11
NO981434D0 (no) 1998-03-30
AR253777A1 (es) 2001-10-08
NO981431L (no) 1994-12-09
HU9402913D0 (en) 1995-01-30
NO305024B1 (no) 1999-03-22
FI944713A0 (fi) 1994-10-07
IL105328A0 (en) 1993-08-18
KR950700881A (ko) 1995-02-20
KR100257805B1 (ko) 2000-07-01
FI20002460A (fi) 2000-11-09
CA2117892A1 (en) 1993-10-28
JP2004285072A (ja) 2004-10-14
NO943794L (no) 1994-12-09
NO981434L (no) 1994-12-09
NO305023B1 (no) 1999-03-22
JPH08502022A (ja) 1996-03-05
NO981432L (no) 1994-12-09
FI944713A (fi) 1994-12-02
FI106454B (fi) 2001-02-15
IL105328A (en) 2007-03-08
CA2117892C (en) 2001-12-18
NO943794D0 (no) 1994-10-07
EP0635004A1 (en) 1995-01-25
NZ251132A (en) 1996-12-20
PT635004E (pt) 2002-12-31
AU3797393A (en) 1993-11-18
NO981433L (no) 1994-12-09
NO981433D0 (no) 1998-03-30
NO981431D0 (no) 1998-03-30
NO981432D0 (no) 1998-03-30
NO305076B1 (no) 1999-03-29
MX9302076A (es) 1994-03-31
EP0635004B1 (en) 2002-07-17
WO1993021156A1 (en) 1993-10-28
DE69332117T2 (de) 2003-01-30
NO305077B1 (no) 1999-03-29
AU671822B2 (en) 1996-09-12

Similar Documents

Publication Publication Date Title
ES2176201T3 (es) Derivados de 4-difenilmetil piperidina y procedimiento de preparacion.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2055119T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y de la desacetil-10 bacatina iii.
ES2011210T3 (es) Derivados de gem-difosfonato substituido, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
SV1998000029A (es) Compuestos de pirazina ref. pg3186
ES2095059T3 (es) Productos intermedios en un procedimiento para la purificacion de acido clavulanico.
ES2077399T3 (es) Derivados de poli-4-aminopirrol-2-carboxiamida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR016973A1 (es) Uso de aminometil-cromanos sustituidos para la produccion de un medicamento util para el tratamiento de enfermedades neurodegenerativas y para el estimulode la regeneracion neuronal
AR003451A1 (es) Derivados de piperazina, una composicion farmaceutica que los comprende, el uso de los mismos y un metodo para su preparacion.
AR007088A1 (es) 2,4-diaminopirimidinas sustituidas, compuestos intermedios utilizados en su preparacion, procedimiento para la preparacion de dichas 2,4-diaminopirimidinas sustituidas, medicamentos que las contienen y empleos de dichas pirimidinas
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2189717T3 (es) Derivados de 2,5-diamino-1-amino-metil-benceno y productos que los contienen, y su uso para el teñido de fibras de queratina.
AR012601A1 (es) Derivados de amidina, formulaciones farmaceuticas que los contiene, uso de dichos derivados en la preparacion de medicamentos y proceso para lapreparacion de dichos derivados
ES2110030T3 (es) Nuevos derivados de 17-hidroxiiminometil-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.
ES2183786T3 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos, procedimiento para su preparacion y su empleo como medicamentos.
AR034583A1 (es) Compuestos de isoindoloindolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
MX9300008A (es) Nucleosidos terapeuticos.